Bayer Healthcare LLC et al v. Padagis Israel Pharmaceuticals Ltd., et al
| Bayer Healthcare LLC and Meda Pharmaceuticals Inc. |
| Padagis Israel Pharmaceuticals Ltd., Padagis US LLC and Padagis LLC |
| 1:2023cv01148 |
| October 13, 2023 |
| US District Court for the District of Delaware |
| William C Bryson |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 1 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on December 4, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 10 WAIVER OF SERVICE returned executed by Bayer HealthCare LLC: For Padagis Israel Pharmaceuticals Ltd. waiver sent on 11/30/2023, answer due 1/29/2024. (Fahnestock, Derek) |
| Filing 9 WAIVER OF SERVICE returned executed by Bayer HealthCare LLC: For Padagis US LLC waiver sent on 11/30/2023, answer due 1/29/2024. (Fahnestock, Derek) |
| Filing 8 WAIVER OF SERVICE returned executed by Bayer HealthCare LLC: For Padagis LLC waiver sent on 11/30/2023, answer due 1/29/2024. (Fahnestock, Derek) |
| Case Assigned to Judge William C. Bryson of the United States Court of Appeals for the Federal Circuit. Please include the initials of the Judge (WCB) after the case number on all documents filed. (nms) |
| Filing 7 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Viatris Inc. for Meda Pharmaceuticals Inc. filed by Meda Pharmaceuticals Inc.. (Cordo, Andrew) |
| Filing 6 Summons Issued as to Padagis Israel Pharmaceuticals Ltd. on 10/13/2023; Padagis LLC on 10/13/2023; Padagis US LLC on 10/13/2023. (Attachments: #1 Summons Issued, #2 Summons Issued) (vfm) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Bayer AG for Bayer Healthcare LLC filed by Bayer Healthcare LLC. (vfm) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,071,073 B2 ;8,518,919 B2 ;9,919,050 B2. (vfm) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 09/01/2023. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 3/1/2026. (vfm) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (vfm) |
| Filing 1 COMPLAINT for ANDA/PATENT INFRINGEMENT filed against Padagis Israel Pharmaceuticals Ltd., Padagis LLC, Padagis US LLC ( Filing fee $ 402, receipt number ADEDC-4247648.) - filed by Bayer Healthcare LLC, Meda Pharmaceuticals Inc.. (Attachments: #1 Exhibit A-C, #2 Civil Cover Sheet) (vfm) |
| DEFICIENCY NOTICE issued by the Court to Plaintiff Meda Pharmaceuticals Inc.: Pursuant to Fed. R. Civ. P. 7.1 (b)(1), A party must: (1) file the disclosure statement with its first appearance, pleading, petition, motion, response, or other request addressed to the court. Counsel is requested to supplement the docket with an appropriate Rule 7.1 Disclosure Statement. (vfm) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
